Virus Supply Vexes Gene Therapy Developers, CMOs – Genetic Engineering & Biotechnology News
Genetic Engineering & Biotechnology News |
Virus Supply Vexes Gene Therapy Developers, CMOs
Genetic Engineering & Biotechnology News Rapid advancement of gene therapies into the clinic carries with it a challenge for developers and manufacturers. Why? Because demand for virus currently exceeds supply—and demand is growing at a rapid pace. Companies developing gene therapies and … |
